SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Lock Up Expiration Hell Portfolio: Wave II
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (35)7/21/2004 2:20:47 PM
From: tuck  Read Replies (1) of 107
 
Past experience showed that shorting was done well before lock up expiration. Summertime blues has hit biotechs with a vengeance, creating some opportunities. Buying CYTK for $10. 1000 shares. And nibbling some CGTK 300 shares at $14.70.

Anyone else got ideas? Wait some more? Buy something now?

Keep EYET short? Cover?

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News